Association of selected factors with long-term prognosis and mortality after dual-chamber pacemaker implant.


Journal

Cardiology journal
ISSN: 1898-018X
Titre abrégé: Cardiol J
Pays: Poland
ID NLM: 101392712

Informations de publication

Date de publication:
2019
Historique:
received: 19 02 2018
accepted: 18 06 2018
revised: 17 05 2018
pubmed: 30 8 2018
medline: 4 8 2020
entrez: 30 8 2018
Statut: ppublish

Résumé

Dual-chamber (DDD) pacing is the most widely utilised pacing modality in many parts of the world. The present study aimed to evaluate life expectancy of DDD pacemaker patients in comparison to the age- and sex-matched general population, assess changes in baseline characteristics over three decades of the inclusion period and determine the association between selected variables and patient survival. This longitudinal study of consecutive de novo DDD pacemaker implantations performed between 1984 and 2014, with all-cause mortality until 2016 as the endpoint, was conducted at a singlecenter university hospital. Under assessment were 3928 patients with a total of 30,087 patient-years of survival time. Compared to the general population, the observed survival was significantly inferior until 12 years post DDD pacemaker implant (HR = 1.499, p < 0.001), whereas after 12 years of follow-up the observed survival was significantly superior (HR = 0.555, p < 0.001). A comparison of patient baseline characteristics over three decades revealed the following significant changes: more elderly patients, more female patients, less patients with atrioventricular block, more patients with atrial fibrillation/atrial flutter (AF/AFL) and fewer patients with an apical right ventricular (RV) lead position in the later decades. In multivariate analysis male sex and higher age were the only variables significantly associated with shorter survival time. Indication for pacing, history of pre-implant AF/AFL, RV lead position and device infection were not associated with survival. In the very-long-term follow-up of DDD pacemaker patients, the parameters associated with survival were sex and baseline age at first implantation.

Sections du résumé

BACKGROUND
Dual-chamber (DDD) pacing is the most widely utilised pacing modality in many parts of the world. The present study aimed to evaluate life expectancy of DDD pacemaker patients in comparison to the age- and sex-matched general population, assess changes in baseline characteristics over three decades of the inclusion period and determine the association between selected variables and patient survival.
METHODS
This longitudinal study of consecutive de novo DDD pacemaker implantations performed between 1984 and 2014, with all-cause mortality until 2016 as the endpoint, was conducted at a singlecenter university hospital.
RESULTS
Under assessment were 3928 patients with a total of 30,087 patient-years of survival time. Compared to the general population, the observed survival was significantly inferior until 12 years post DDD pacemaker implant (HR = 1.499, p < 0.001), whereas after 12 years of follow-up the observed survival was significantly superior (HR = 0.555, p < 0.001). A comparison of patient baseline characteristics over three decades revealed the following significant changes: more elderly patients, more female patients, less patients with atrioventricular block, more patients with atrial fibrillation/atrial flutter (AF/AFL) and fewer patients with an apical right ventricular (RV) lead position in the later decades. In multivariate analysis male sex and higher age were the only variables significantly associated with shorter survival time. Indication for pacing, history of pre-implant AF/AFL, RV lead position and device infection were not associated with survival.
CONCLUSIONS
In the very-long-term follow-up of DDD pacemaker patients, the parameters associated with survival were sex and baseline age at first implantation.

Identifiants

pubmed: 30155863
pii: VM/OJS/J/57334
doi: 10.5603/CJ.a2018.0093
pmc: PMC8083035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

717-726

Références

Europace. 2008 Jul;10(7):825-31
pubmed: 18467299
Europace. 2013 Aug;15(8):1070-118
pubmed: 23801827
Am Heart J. 2008 May;155(5):896-903
pubmed: 18440339
Heart. 2013 Nov;99(21):1573-8
pubmed: 23969476
Am Heart J. 2003 Nov;146(5):887-93
pubmed: 14597940
N Engl J Med. 2002 Jun 13;346(24):1854-62
pubmed: 12063369
Pacing Clin Electrophysiol. 1992 Feb;15(2):141-7
pubmed: 1372412
Europace. 2010 Feb;12(2):210-5
pubmed: 19864309
Pacing Clin Electrophysiol. 2011 Aug;34(8):1013-27
pubmed: 21707667
N Engl J Med. 2000 May 11;342(19):1385-91
pubmed: 10805823
J Am Coll Cardiol. 1999 Apr;33(5):1208-16
pubmed: 10193718
Europace. 2012 Apr;14(4):496-501
pubmed: 22071380
Europace. 2013 Jan;15(1):66-70
pubmed: 23097224
Lancet. 2015 Jul 11;386(9989):154-62
pubmed: 25960110
Medicine (Baltimore). 2016 Aug;95(35):e4668
pubmed: 27583889
J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6
pubmed: 21867833
N Engl J Med. 2005 Jul 14;353(2):145-55
pubmed: 16014884
Pacing Clin Electrophysiol. 1999 Mar;22(3):407-12
pubmed: 10192849
Int J Cardiol. 2015;190:42-6
pubmed: 25912118
Acta Cardiol. 2016 Feb;71(1):41-5
pubmed: 26853252
Europace. 2002 Apr;4(2):113-9
pubmed: 12135241
J Am Coll Cardiol. 2012 Oct 16;60(16):1540-5
pubmed: 22999727
Europace. 2010 Feb;12(2):202-9
pubmed: 19903671
Heart. 2012 May;98(9):724-31
pubmed: 22523057
Eur Heart J. 2011 Mar;32(6):686-96
pubmed: 21300730
Kardiol Pol. 2014;72(6):519-26
pubmed: 24526555
Eur Heart J. 2004 Jan;25(1):88-95
pubmed: 14683747
J Cardiovasc Electrophysiol. 2017 Aug;28(8):924-930
pubmed: 28543771

Auteurs

Maciej Dębski (M)

Department of Electrocardiology John Paul II Hospital in Krakow. maciekdebski@gmail.com.

Mateusz Ulman (M)

Department of Electrocardiology John Paul II Hospital in Krakow.

Andrzej Ząbek (A)

Department of Electrocardiology John Paul II Hospital in Krakow.

Krzysztof Boczar (K)

Department of Electrocardiology John Paul II Hospital in Krakow.

Kazimierz Haberka (K)

Department of Electrocardiology John Paul II Hospital in Krakow.

Marcin Kuniewicz (M)

Department of Electrocardiology John Paul II Hospital in Krakow.
Department of Anatomy, Jagiellonian University Medical College, Krakow.

Jacek Lelakowski (J)

Department of Electrocardiology John Paul II Hospital in Krakow.
Institute of Cardiology, Jagiellonian University Medical College, Krakow.

Barbara Małecka (B)

Department of Electrocardiology John Paul II Hospital in Krakow.
Institute of Cardiology, Jagiellonian University Medical College, Krakow.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH